US8889706B2ActiveUtilityPatentIndex 91
Soluble mTOR complexes and modulators thereof
Est. expiryOct 17, 2028(~2.3 yrs left)· nominal 20-yr term from priority
Inventors:GRAY NATHANAELCHANG JAE-WONZHANG JIANMINGTHOREEN CARSON CKANG SEONG WOO ANTHONYSABATINI DAVID MLIU QINGSONG
A61P 35/00A61P 3/00C07D 498/04A61P 3/04C07D 471/04C07D 471/14C07D 519/00
91
PatentIndex Score
31
Cited by
46
References
6
Claims
Abstract
The present invention relates to small molecule modulators of mTORC1 and mTORC2, syntheses thereof, and intermediates thereto. Such small molecule modulators are useful in the treatment of proliferative diseases (e.g., benign neoplasms, cancers, inflammatory diseases, autoimmune diseases, diabetic retinopathy) and metabolic diseases. Novel small molecules are provided that inhibit one or more of mTORC1, mTORC2, and PI3K-related proteins. Novel methods of providing soluble mTORC1 and mTORC2 complexes are discussed, as well as methods of using the soluble complexes in a high-throughput manner to screen for inhibitory compounds.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound selected from the group consisting of:
and pharmaceutically acceptable salts thereof.
2. The compound according to claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
3. The compound according to claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable excipient.
5. A pharmaceutical composition comprising a compound according to claim 2 and a pharmaceutically acceptable excipient.
6. A pharmaceutical composition comprising a compound according to claim 3 and a pharmaceutically acceptable excipient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.